REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Atb Pharma, S.R.O. (Slovakia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Atb Pharma, S.R.O. Profile Updated: October 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Atb Pharma, S.R.O. is a company in Slovakia, with a head office in Martin. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on February 28, 2017. 50 - 99 (2023) employees currently work for Atb Pharma, S.R.O.. From the latest financial highlights, Atb Pharma, S.R.O. reported a net sales revenue drop of 5.64% in 2023. Over the same period, its total assets grew by 2.35%.

Headquarters
Sklabinska, 28
Martin; Zilinsky; Postal Code: 03601

Contact Details: Purchase the Atb Pharma, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Atb Pharma, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Atb Pharma, S.R.O. report to view the information.
Registered Capital:
Purchase the Atb Pharma, S.R.O. report to view the information.
Incorporation Date:
February 28, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
85%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Atb Pharma, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-5.64%▼
Total operating revenue
-5.67%▼
Operating profit (EBIT)
-95.37%▼
EBITDA
-65.56%▼
Net Profit (Loss) for the Period
N/A
Total assets
2.35%▲
Total equity
-5.08%▼
Operating Profit Margin (ROS)
-14.67%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
24.37%▲
Quick Ratio
0.02%▲
Cash Ratio
-0%

Similar companies

Johnson & Johnson, S.R.O.
 
Novartis Slovakia S.R.O.
Saneca Pharmaceuticals a. s.
 
HBM Pharma s.r.o.
Hartmann - Rico spol. s r.o.
 
BB Pharma s.r.o.
Panacea, s.r.o.
 
Farmacia Martin A.S.
Galvex, spol. s r.o.
 
Biomin, a.s.
Pharmagal, Spol. S.R.O.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo